Undertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset | Zendy

Jordi Monés | Zendy; Rishi P. Singh | Zendy; Francesco Bandello | Zendy; Eric H. Souied | Zendy; Xin Liu | Zendy; Richard Gale | Zendy

Open Access

Undertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset

Author(s) -

Jordi Monés,

Rishi P. Singh,

Francesco Bandello,

Eric H. Souied,

Xin Liu,

Richard Gale

Publication year - 2019

Publication title -

ophthalmologica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.639

H-Index - 60

eISSN - 1423-0267

pISSN - 0030-3755

DOI - 10.1159/000502747

Subject(s) - mindset , medicine , macular degeneration , virtuous circle and vicious circle , clinical trial , visual acuity , intensive care medicine , clinical practice , ophthalmology , physical therapy , philosophy , epistemology , economics , macroeconomics

To assess the gap between visual acuity (VA) outcomes with anti-vascular endothelial growth factor (anti-VEGF) therapies in clinical trials and real-world practice, and explore the reasons for this gap.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research